Partner Content Partner Content Exclusive interview with AstraZeneca ahead of upcoming Weara... Wearable Injectors & Connected Devices
Partner Content Partner Content Department for International Trade to present at Wearable In... Wearable Injectors and Connected Devices Conference
Partner Content Partner Content AstraZeneca to lead a workshop during the Wearable Injectors... Wearable Injectors and Connected Devices Conference
Partner Content Partner Content Registration is now open for the inaugural Wearable Injector... Registration open for the inaugural Wearable Injectors
Digital Eyeforpharma Barcelona 2019 roundup This year’s eyeforpharma Barcelona conference might have seemed all doom and gloom at the outset, with many predicting the downfall of pharma as we know it – but there were plenty of speake
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.